On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.1 at the end of 2023 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Additionally, we assume a more than 50% probability of Sanofi seeing future costs related to product governance ESG risks (such as off-label marketing or litigation related to side effects ...

“Ranitidine, used for acid reflux ... Cymbalta—duloxetine hydrochloride capsule, delayed release [drug label].

One shadow still lingering over GSK, however, is ongoing litigation claiming that its Zantac (ranitidine) gastrointestinal product caused cancer in patients. The company has won some early rounds ...

The Zantac litigation continues in federal and ... we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use. A digital health passport is an app, or online ...

Prolonged Q-T interval Hospitalization 80 (07/09/2001, occurred 9/27/1991) 37, M Droperidol 125 mg, ranitidine, clomeiethiazole, nifedipine, metoprolol, potassium chloride Ventricular fibrillation ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...

GSK (GSK) used its third-quarter trading update to draw a definitive line under the damaging litigation around its now discontinued heartburn medicine Zantac, by agreeing a settlement earlier in ...

Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed ...